Susan Smith
Förmögenhet: 2 991 $ per 2026-06-30
Förmögenhet: 2 991 $ per 2026-06-30
Susan Smith is currently the Chief Executive Officer at The Portland Hospital For Women & Children.
She is also the Vice Chairman at Clinuvel Pharmaceuticals Ltd., the Chairman at Evewell Group Ltd., and the Director at HCA Hope Fund.
Previously, she held the position of Chief Executive Officer at The Princess Grace Hospital and The Independent Doctors Federation.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-06-30 | 420 ( 0 % ) | 2 991 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Direktör/Styrelseledamot | 2019-09-23 |
Evewell Group Ltd. | Ordförande | - |
HCA Hope Fund | Direktör/Styrelseledamot | - |
The Portland Hospital For Women & Children
The Portland Hospital For Women & Children Hospital/Nursing ManagementHealth Services Operates hospitals | Verkställande Direktör | - |
| Företag | Position | Slut |
|---|---|---|
The Princess Grace Hospital | Verkställande Direktör | - |
The Independent Doctors Federation | Verkställande Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Clinuvel Pharmaceuticals Ltd.
Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
The Princess Grace Hospital | |
HCA Hope Fund | |
The Independent Doctors Federation | |
The Portland Hospital For Women & Children
The Portland Hospital For Women & Children Hospital/Nursing ManagementHealth Services Operates hospitals | Health Services |
Evewell Group Ltd. |
Välj din utgåva
All finansiell information anpassad till den nationella nivån